Abstract

Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
B.J Monk ... U.A Matulonis
Annals of Oncology | VOL. 28
B.J Monk, et. al.B.J Monk ... U.A Matulonis
01 Mar 2017
Abstract 2402: Antitumor effect of a poly (ADP-ribose) polymerase (PARP) inhibitor in endometrial carcinoma cell lines
Takahiro Koso ... Yuriko Uehara
Cancer Research | VOL. 74
Takahiro Koso, et. al.Takahiro Koso ... Yuriko Uehara
30 Sep 2014
PO-462 Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects
N Verkaik ... J Martens
ESMO Open | VOL. 3
N Verkaik, et. al.N Verkaik ... J Martens
01 Jul 2018
The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review
Sanjay Maraboyina ... Somaira Nowsheen
Cell & Bioscience | VOL. 10
Sanjay Maraboyina, et. al.Sanjay Maraboyina ... Somaira Nowsheen
11 Mar 2020
View more papers

More From: JCO Precision Oncology

Paper Title
Journal
Date
Author
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants.
André B P Van Kuilenburg ... Klary E Niezen-Koning
JCO precision oncology | VOL. 8
André B P Van Kuilenburg, et. al.André B P Van Kuilenburg ... Klary E Niezen-Koning
01 May 2024
Scoping Review of Barriers and Facilitators to Recruitment of Black People With Cancer in Biospecimen-Based Research.
Hayley N Morris ... Marjory Charlot
JCO precision oncology | VOL. 8
Hayley N Morris, et. al.Hayley N Morris ... Marjory Charlot
01 May 2024
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group.
Richard Do ... Lesley Seymour
JCO precision oncology | VOL. 8
Richard Do, et. al.Richard Do ... Lesley Seymour
01 May 2024
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.
Kumar Prabhash ... Pratik Chandrani
JCO precision oncology | VOL. 8
Kumar Prabhash, et. al.Kumar Prabhash ... Pratik Chandrani
01 May 2024
View more papers